Scientific and methodological approaches to the assessment of intellectual potential of domestic pharmaceutical companies

Journal Title: Фармацевтичний журнал - Year 2016, Vol 6, Issue 6

Abstract

Currently, the state and effectiveness of intellectual resources management system define competitiveness, strategic position and prospects of the development of modern pharmaceutical companies. The aim is to study scientific and methodological approaches to the assessment and management of intellectual resources of domestic pharmaceutical companies with a view to identify the reserves for increasing process management. It has analyzed the level of intellectual resources (market share of pharmaceutical companies, the share of innovative drugs in the portfolio of pharmaceutical companies, the share of commercialized intellectual property, the personnel component of intellectual resources; as of June 2016) in domestic pharmaceutical companies. Analysis of intellectual resources of Ukrainian pharmaceutical companies has allowed to identify 4 groups. The first group includes pharmaceutical companies, which have the highest value of the integral index of intellectual resources, as well as the high share of controlled pharmaceutical market. This group includes pharmaceutical companies: CJSC «Farmak», Pharmaceutical firm «Darnytsa», pharmaceutical company «Zdorovie», «Arterium» Corporation. The analysis has shown that this pharmaceutical companies with a view to retain its market position it is reasonable to use offensive innovation strategy. Analysis of effective intellectual resource management in domestic pharmaceutical companies as PJSC SIC «Borshchahivskiy CPP», PC «Kyiv Vitamin Factory», JSC «Lekhim», PJSC «Red star», «Yuria-Pharm», PC «Fitofarm» (the second group) has showed that the gradual intensification of innovation activity will allow to remain significant players in Ukrainian pharmaceutical market, especially for this they have appropriate technical, financial, human and scientific potential. It is proved that the management of intellectual resources in the pharmacy should be system administered at the macro, meso, micro levels, and provide for the development of cross-level relationships that contribute to the sustainable development of the domestic pharmacy.

Authors and Affiliations

О. V. Litvinova, O. V. Posilkina

Keywords

Related Articles

Research of acute toxicity of the drug HEXIA

Diseases of the genitourinary system caused by pathogenic and potentially pathogenic microorganisms, which result into disbiosis of urinary organs, remain an urgent problem of dermatovenereology, gynecology and urology,...

Research of pharmaceutical market of the foam aerosols

Medical and pharmaceutical foams are therapeutics systems which determine foams as a class of medicines systems modified by release of active pharmaceutical ingredients. Foams are structured disperse system in the form o...

Researches of the assortment of drugs for the treatment of diabetes II type оn the pharmaceutical market of Ukraine

Type II diabetes is a global pandemic, as evidenced by data from a study by the International Diabetes Federation. The disease is a chronic, progressive process with a special metabolic condition that is characterized by...

Decametoxin and chlorhexidin at the domestic pharmaceutical market

Realization of marketing researches of home pharmaceutical market in the presence of drugs farmakotherapeutic group always is actual, as he allows to find out gap-fillingness of market of medications. The aim of this ana...

The component composition and antimicrobal activity of the essential oil from inflorescences of Tagetes erecta L.

Tagetes erecta L. is the promising materials for new medicines. The study of composition of Tagetes erecta L. is of great practical and scientific importance. The aim of this scientific work is the determinate of physic...

Download PDF file
  • EP ID EP565621
  • DOI -
  • Views 55
  • Downloads 0

How To Cite

О. V. Litvinova, O. V. Posilkina (2016). Scientific and methodological approaches to the assessment of intellectual potential of domestic pharmaceutical companies. Фармацевтичний журнал, 6(6), 5-14. https://europub.co.uk/articles/-A-565621